Literature DB >> 7611244

Macrophages and progressive renal disease in experimental hydronephrosis.

J R Diamond1.   

Abstract

Many recent clinical and experimental studies have clearly demonstrated that one of the initial events taking place in the process of progressive renal injury is monocytic infiltration of the glomerular and tubulointerstitial compartments. In this report, experimental data supporting the role of the infiltrating renal macrophage (M phi) as a mediator of interstitial fibrosis during the course of obstructive nephropathy will be reviewed as it pertains to the unilateral ureteral obstruction model in the rat. The central pathobiologic theme drawn on data from this model is that fibrogenic cytokines, especially transforming growth factor-beta, are, in part, M phi-derived and represent pivotal links between the initial postobstructive renal inflammation and the late development of renal scarring. The tubular epithelium, as a consequence of the mechanical disturbance produced by ureteral obstruction, may elaborate a host of M phi chemoattractant moieties. Many substances can be released by these infiltrating M phi; however, our studies have focused on transforming growth factor-beta 1. Transforming growth factor-beta is an important regulator of extracellular matrix, through its direct effects and modulation of other growth factors to maintain matrix homeostasis. We propose that the markedly increased expression of transforming growth factor-beta 1 following ureteral ligation, as detected by a number of laboratories, induces a profibrogenic state and initiates a cascade of dysregulatory events, including the upregulation of tissue inhibitors of metalloproteinase. Transforming growth factor-beta 1 also may serve as a potent stimulus for the modulation of quiescent interstitial fibroblasts into myofibroblasts. From a therapeutic standpoint, targeting these early cellular and molecular events may be extremely important in interrupting the interstitial fibrotic response to long-term obstructive uropathy.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7611244     DOI: 10.1016/0272-6386(95)90166-3

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  20 in total

1.  Decorin-mediated regulation of fibrillin-1 in the kidney involves the insulin-like growth factor-I receptor and Mammalian target of rapamycin.

Authors:  Liliana Schaefer; Wasiliki Tsalastra; Andrea Babelova; Martina Baliova; Jens Minnerup; Lydia Sorokin; Hermann-Josef Gröne; Dieter P Reinhardt; Josef Pfeilschifter; Renato V Iozzo; Roland M Schaefer
Journal:  Am J Pathol       Date:  2007-01       Impact factor: 4.307

2.  Identification and regulation of reticulon 4B (Nogo-B) in renal tubular epithelial cells.

Authors:  Ethan P Marin; Gilbert Moeckel; Rafia Al-Lamki; John Bradley; Qingshang Yan; Tong Wang; Paulette L Wright; Jun Yu; William C Sessa
Journal:  Am J Pathol       Date:  2010-10-22       Impact factor: 4.307

3.  Nitric oxide is an important mediator of renal tubular epithelial cell death in vitro and in murine experimental hydronephrosis.

Authors:  Tiina Kipari; Jean-Francois Cailhier; David Ferenbach; Simon Watson; Kris Houlberg; David Walbaum; Spike Clay; John Savill; Jeremy Hughes
Journal:  Am J Pathol       Date:  2006-08       Impact factor: 4.307

4.  P2X(7) receptor at the heart of disease.

Authors:  Ei Vasileiou; R M Montero; C M Turner; G Vergoulas
Journal:  Hippokratia       Date:  2010-07       Impact factor: 0.471

5.  Galectin-3 expression and secretion links macrophages to the promotion of renal fibrosis.

Authors:  Neil C Henderson; Alison C Mackinnon; Sarah L Farnworth; Tiina Kipari; Christopher Haslett; John P Iredale; Fu-Tong Liu; Jeremy Hughes; Tariq Sethi
Journal:  Am J Pathol       Date:  2008-01-17       Impact factor: 4.307

6.  Role of inflammation in túbulo-interstitial damage associated to obstructive nephropathy.

Authors:  María T Grande; Fernando Pérez-Barriocanal; José M López-Novoa
Journal:  J Inflamm (Lond)       Date:  2010-04-22       Impact factor: 4.981

7.  Macrophage matrix metalloproteinase-9 mediates epithelial-mesenchymal transition in vitro in murine renal tubular cells.

Authors:  Thian Kui Tan; Guoping Zheng; Tzu-Ting Hsu; Ying Wang; Vincent W S Lee; Xinrui Tian; Yiping Wang; Qi Cao; Ya Wang; David C H Harris
Journal:  Am J Pathol       Date:  2010-01-14       Impact factor: 4.307

8.  Transforming growth factor-beta-dependent and -independent pathways of induction of tubulointerstitial fibrosis in beta6(-/-) mice.

Authors:  Li-Jun Ma; Haichun Yang; Ariana Gaspert; Gianluca Carlesso; Melissa M Barty; Jeffrey M Davidson; Dean Sheppard; Agnes B Fogo
Journal:  Am J Pathol       Date:  2003-10       Impact factor: 4.307

9.  Heme oxygenase-1 deficiency promotes epithelial-mesenchymal transition and renal fibrosis.

Authors:  Jeong-Hae Kie; Matthias H Kapturczak; Amie Traylor; Anupam Agarwal; Nathalie Hill-Kapturczak
Journal:  J Am Soc Nephrol       Date:  2008-05-21       Impact factor: 10.121

10.  PPARgamma agonist and angiotensin II receptor antagonist ameliorate renal tubulointerstitial fibrosis.

Authors:  Jee-Young Han; Ye-Ji Kim; Lucia Kim; Suk-Jin Choi; In-Suh Park; Joon-Mee Kim; Young Chae Chu; Dae-Ryong Cha
Journal:  J Korean Med Sci       Date:  2009-12-29       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.